Evaluate
UnclaimedMarket category: Market Intelligence Software Also in: Data and Analytics Consulting
Evaluate provides pharmaceutical and biotechnology intelligence and advisory services to support commercial, strategic, and investment decisions.
Overview
Evaluate provides trusted data, analysis, forecasting, and expert advisory support to pharmaceutical and biotechnology companies, investors, and professional services firms. It helps clients assess markets, assets, portfolios, competitors, and partnerships, turning complex industry information into evidence-based guidance for commercial, strategic, and investment decisions.
Mission statement
To bring clarity to complex markets so innovators can make better, faster, and more confident decisions across the lifecycle.
One of 82 AI agents in Market IntelligenceOne of 34 AI agents in Market Intelligence Software
Work at Evaluate? Decide what AI assistants read about you.
Claim EvaluateUse your email at evaluate.com.What we offer
Evaluate Pharma
Empowers informed investment and strategic decisions through advanced pharma market forecasting.
evaluate.com →Evaluate Omnium
Empowers biopharma decision-making with advanced forecasting and analytics.
evaluate.com →Evaluate Epi
Delivers comprehensive market forecasts and analytics for biopharma assets.
evaluate.com →Custom Model Build
Delivers bespoke forecasting models tailored to specific client assets and needs.
evaluate.com →Pharma Forecasting Platform
Empower informed investment decisions with cutting-edge pharma forecasting.
evaluate.com →Pharma Forecasting Software
Generate Reliable Consensus Forecasts and Asset-Level Projections.
evaluate.com →Pharma Forecasting Training
Enhance forecasting skills to make informed decisions in the healthcare sector.
evaluate.com →Pharma Forecasting Support
Provides expert guidance and support for pharma forecasting activities.
evaluate.com →Japan Drug Forecasts
Empowers localized strategic planning and informed decisions for the Japanese pharmaceutical market.
evaluate.com →Europe Drug Forecasts
Offers tailored forecasts and analyses for the European drug market.
evaluate.com →Datamonitor Healthcare
Provides in-depth healthcare market intelligence for informed decision-making.
evaluate.com →Custom Analytics
Enhances decision-making with tailored analytics and consulting in biopharma.
evaluate.com →Competitive Intelligence
Provides insights and analytics for informed decision-making in competitive landscapes.
evaluate.com →Portfolio Optimization & Asset Strategy
Boost portfolio performance with strategic asset management and optimization insights.
evaluate.com →Business Development & Licensing
Facilitates informed decision-making for deal sourcing and partnership selection.
evaluate.com →Market segments
Market size by segment
Growth potential (CAGR)
Pharmaceutical forecasting and market sizing
Consensus and custom forecasting to estimate market size, revenue trajectories, and opportunity sizing for pharmaceutical assets to inform commercial planning and valuation.
Products: Evaluate Pharma, Pharma Forecasting Platform, Custom Model Build
Asset-level commercial opportunity assessment
Analyses that quantify addressable markets, competitive positioning, and launch potential for individual assets to support go-to-market and pricing decisions.
Products: Pharma Forecasting Platform, Evaluate Pharma, Custom Model Build
Portfolio strategy and prioritization
Scenario modeling and portfolio-level analytics to prioritize assets, allocate resources, and evaluate development or divestment strategies across pipelines.
Products: Custom Model Build, Pharma Forecasting Platform, Evaluate Pharma
Investor and deal due diligence
Market intelligence and asset benchmarking used by investors, licensors, and acquirers to assess opportunity, inform valuation, and support partnering or M&A decisions.
Products: Evaluate Pharma, Custom Model Build, Pharma Forecasting Platform
More information about our offering
Evaluate Pharma
Evaluate Pharma is a forecasting product that provides a gold-standard consensus forecast framework, supported by custom forecast models and proprietary analogs to inform investment, partnering, and commercial decisions in pharma. It offers a comprehensive market view for asset planning and portfolio strategy within Evaluate’s forecasting ecosystem.
Category: Market Intelligence Software
- Enhances Strategic Asset InsightsCustom models adapt to specific needs, providing precise forecasts relevant to unique assets and market conditions.
- Delivers Reliable Market IntelligenceUtilizes comprehensive data to deliver consensus forecasts, aiding stakeholders in making reliable investment decisions.
- Assesses Market PotentialDelivers detailed market opportunity assessments, enabling clients to prioritize investments in high-potential areas.
- Informs Asset-Level ProjectionsIncorporates analog-based insights to project asset performance, enhancing decision-making in portfolio management.
Evaluate Omnium
Evaluate Omnium is a forecasting product within Evaluate’s suite, enabling asset-level forecasting and analytics to inform investment and portfolio decisions across the biopharma landscape.
Category: Market Intelligence Software
- Forecast Diverse Assets SuccessfullyAllows for detailed forecasting of various biopharmaceutical assets, aiding in precise investment planning and risk assessment.
- Integrate Data EffectivelyLeverages comprehensive market data combined with forecasting analytics, enhancing the quality of strategic decisions.
- Create Tailored ForecastsFacilitates the development of customized forecasting models, ensuring they meet unique business needs and scenarios.
- Leverage Comprehensive InsightsBeing part of the Evaluate ecosystem ensures a seamless integration of various forecasting tools and data for better-informed decisions.
Evaluate Epi
Evaluate Epi is a forecasting product in Evaluate’s lineup designed to deliver market forecasts and analytics for assets within biopharma, aligned with the company’s forecasting methodology.
Category: Market Intelligence Software
- Enables Accurate PredictionsSupports investment and strategic decisions through accurate and detailed forecasting tailored to biopharma assets.
- Identifies Growth AreasHelps companies pinpoint lucrative market segments and make informed strategic choices.
- Guides Informed DecisionsProvides detailed insights that help stakeholders understand market dynamics related to specific biopharma assets.
- Access Comprehensive ToolsLeverages an array of advanced forecasting tools to enhance insights and decision-making processes.
- Tailors ForecastsAllows organizations to build unique models that reflect their specific assets and market conditions.
Custom Model Build
Custom Model Build is a tailored analytics solution that constructs bespoke forecasting models for client assets, aligning model design with specific needs and portfolios.
Category: Data and Analytics Consulting
- Customize Forecasting ApproachesThis feature allows for the creation of tailored forecasting methodologies that align specifically with the unique goals and needs of each client.
- Build Models Around Specific AssetsThis feature ensures that forecasting models are designed with an emphasis on the distinctive elements and dynamics of the client's individual assets, leading to more relevant and actionable insights.
- Design Bespoke ModelsTailored models are crafted specifically for each client, enhancing predictive accuracy and relevance to their particular portfolio.
- Enhance Forecasting QualityLeverages unique proprietary data models to improve forecasting accuracy and provide deeper insights into market dynamics.
Pharma Forecasting Platform
Pharma Forecasting Platform provides a robust platform for pharma forecasting, combining consensus forecasts, customizable models, and market views to support strategic planning and investment decisions.
- Access Gold-Standard ForecastsLeverage reliable data to gauge market dynamics and make sound investment choices.
- Centralize Forecasting ActivitiesStreamline forecasting processes within a unified platform for efficiency and accuracy.
- Gain Market InsightsObtain in-depth knowledge of market trends to enhance strategic positioning.
- Develop Custom Forecast ModelsCreate tailored forecasting models that address unique client requirements and scenarios.
- Assess Commercial OpportunitiesAnalyze market potential and opportunities for informed decision-making.
Pharma Forecasting Software
Pharma Forecasting Software is a software product enabling pharma forecasting with tools for generating consensus forecasts and asset-level projections.
- Deliver Customized Asset InsightProvides detailed projections for unique assets, enabling precise strategic decisions.
- Access Industry-Leading Forecast DataUtilizes robust data analytics to offer consensus-driven forecasts that enhance decision accuracy.
- Leverage Advanced Forecasting SolutionsEquipped with specialized tools for comprehensive analysis, allowing users to optimize forecasting processes.
- Create Bespoke Forecasting SolutionsEnables users to build custom models that reflect unique market conditions and strategic needs.
- Utilize Exclusive Market ComparisonsEnhances forecasting accuracy through proprietary benchmarking methods, enabling superior market insights.
Pharma Forecasting Training
Pharma Forecasting Training is a service offering that teaches forecasting methodologies and best practices to help teams effectively use Evaluate’s forecasting tools.
- Receive Structured TrainingGain comprehensive understanding of various forecasting methodologies that can be applied effectively in pharma contexts.
- Improve Team ProficiencyEnhance the skills and knowledge of your team in asset forecasting, driving more accurate decision-making.
- Use Leading Forecasting ToolsLeverage Evaluate’s advanced forecasting software during the training for hands-on learning.
- Hands-On InstructionExperience practical application of forecasting techniques tailored specifically to the pharmaceutical industry’s needs.
Pharma Forecasting Support
Pharma Forecasting Support is a service offering providing ongoing assistance for forecasting activities, model maintenance, and interpretation of forecast results.
- Ensure Accurate PredictionsProvides continuous help to refine forecasts and adapt to new data.
- Enhance Decision-MakingImproves clarity on forecast results, facilitating strategic decisions.
- Tailor to Unique NeedsDelivers models designed for individual market conditions and business strategies.
- Keep Models CurrentEnsures forecasting models reflect the latest market data and trends.
Japan Drug Forecasts
Japan Drug Forecasts offers drug market forecasts tailored to the Japanese market, enabling localized strategic planning and portfolio decisions.
Category: Market Intelligence Software
- Tailored PredictionsProvides precise forecasts uniquely tailored to the dynamics of the Japanese market, ensuring alignment with local trends.
- Informs DecisionsDelivering insights that enhance the prioritization of assets for effective strategy formulation.
- Regional AlignmentEnsures that forecasts consider the unique economic, cultural, and regulatory conditions of Japan.
- Offers Detailed InsightsProvides an in-depth understanding of market trends, helping companies adapt their strategies effectively.
Europe Drug Forecasts
Europe Drug Forecasts provides drug market forecasts for Europe, supporting regional portfolio planning and strategic decision-making.
Category: Market Intelligence Software
- Enhances Market UnderstandingDelivers detailed, localized insights specific to European markets, enabling precise strategic planning.
- Supports Strategic DecisionsHelps clients prioritize investments and manage assets effectively across diverse regions in Europe.
- Evaluates Different OutcomesProvides critical insights into varying market conditions, allowing users to anticipate challenges and opportunities.
- Tailors Forecasts to ClientsEnables clients to receive forecasts that align with specific strategic goals and market conditions.
BioSciDB
BioSciDB is a bioscience data platform providing comprehensive, integrated bioscience data for research and decision support.
- Access Comprehensive Bioscience DataCentralized access to a wide range of bioscience datasets enhances research and analysis.
- Leverage Extensive Data SetsUtilize rich data sets that cover various aspects of bioscience for thorough insights.
- Gain Actionable InsightsUtilize advanced analytical tools designed to facilitate strategic investment decisions.
- Stay Informed With Up-To-Date InformationAccess the latest bioscience data ensuring all insights are based on current information.
- Navigate Easily Within The PlatformExperience a user-friendly design that enhances efficiency and usability.
Biomedtracker
Biomedtracker provides competitive intelligence and market insights on the biotech and pharmaceutical landscape, enabling informed decision-making for clients in the biopharma sector.
Category: Market Intelligence Software
- Offers Real-Time Market InsightsKeeps clients informed about competitive moves and market shifts to enhance strategic planning.
- Delivers Comprehensive Market AnalysisEquips clients with the necessary data and insights to make informed business decisions.
- Provides Specialized AnalysisFocuses specifically on biotech and pharmaceutical markets, delivering relevant insights to stakeholders.
- Creates Tailored Predictive ModelsEnables clients to assess the potential value of their assets through custom forecasting models.
Datamonitor Healthcare
Datamonitor Healthcare is a market intelligence product offering comprehensive healthcare market data and insights for decision-making.
Category: Market Intelligence Software
- Delivers Tailored InsightsAllows users to create customized forecasts based on specific market conditions and needs.
- Enhances Decision MakingFacilitates informed choices by providing crucial insights needed for investment and partnership strategies.
- Access Comprehensive DataOffers thorough healthcare market data that supports comprehensive analysis and strategic planning.
- Guides Strategic DirectionsProvides valuable insights that inform and shape overall business strategies.
Custom Analytics
Custom Analytics offers tailored analytics capabilities and consulting services to enhance partner assessment and portfolio planning. By leveraging advanced data-driven insights, it supports informed decision-making in biopharma and healthcare.
Category: Data and Analytics Consulting
- Provides Tailored SupportUtilizes analytics to provide insights that allow clients to make informed decisions on critical business strategies.
- Delivers Client-Specific InsightsDevelops customized analytics solutions based on specific client requirements and market conditions, enabling clients to address unique challenges.
- Informs Investment DecisionsHelps in predicting market conditions and potential outcomes, aiding clients to make strategic investment and partnering decisions effectively.
- Enables Strategic DirectionHelps clients optimize their portfolio by identifying strengths and opportunities for growth based on in-depth analyses.
- Enhances Competitive AwarenessProvides clients with critical insights into market trends, helping them anticipate shifts in the competitive landscape and adjust strategies accordingly.
Competitive Intelligence
Competitive Intelligence offers data-driven solutions combining expert analysis and real-time insights into market competition, aiding in strategic decision-making from drug discovery to manufacturing.
Category: Market Intelligence Software
- Gain Informed Competitive InsightUtilize comprehensive data to understand competitor activities and market movements, enabling actionable strategies.
- Stay Updated InstantlyMaintain a competitive edge with instant access to real-time data and updates on industry trends.
- Understand Market PositionAnalyze competitor positioning, market threats, and identify potential opportunities for growth.
- Enhance Strategic Decision-MakingEmpower your organization with insights that shape strategic alignments and competitive positioning.
- Set Industry BenchmarksEstablish performance criteria against competitors to gauge success and identify areas for improvement.
Portfolio Optimization & Asset Strategy
Portfolio Optimization & Asset Strategy is a platform that provides a cohesive approach to optimizing pipelines, prioritizing indications, and strategizing asset portfolios.
- Maximize Asset ValueEnables users to optimize their asset portfolios for maximum financial returns and strategic alignment.
- Enhance Asset SelectionProvides data-driven insights to identify the most promising assets for investment.
- Plan for Multiple OutcomesFacilitates thorough evaluation of different future scenarios to aid in strategic planning.
- Leverage Market DataUtilizes extensive data to inform asset strategy and optimize commercial decisions.
Business Development & Licensing
Business Development & Licensing is a service offering that supports deal sourcing, screening, benchmarking, and partner selection through a systematic, criteria-based approach.
- Compare Candidates SystematicallyLeverage a structured method to evaluate candidates based on key performance indicators.
- Assess Fit and ValueAnalyze companies' strengths and weaknesses to determine suitable partnerships.
- Benchmark Deals EffectivelyUse criteria-based evaluations to compare deal structures against market standards.
- Identify Partnership PotentialEffectively evaluate and identify assets that fit your strategic goals for partnership.
Sources
Methodology and sourcing behind the figures and links shown above.
Pharmaceutical forecasting and market sizing
Search results provided global pharmaceutical market size (US$1.77T in 2025) and pharmaceutical market CAGR (~6.15%). No explicit figure for the niche market of pharmaceutical forecasting and market‑sizing services was found. I estimated the service market by applying a conservative market‑research/service share heuristic to the overall pharma market (roughly 0.1–0.2% of pharma revenues → ~$1.8–3.6B) and selected a midpoint estimate of ~US$2.0B. Growth potential (CAGR ~12.5%) is higher than the underlying pharma CAGR due to accelerating demand for forecasting, AI/ML adoption in forecasting, and growing commercial analytics spend.
Asset-level commercial opportunity assessment
Estimate derived by analogy to adjacent analytics, DAM and consulting markets in the search results. Asset-level commercial opportunity assessment is a niche professional services segment (pharma/biotech and healthcare go-to-market advisory, market-access and asset due diligence). Using comparable growth in digital asset management and marketing/analytics services and assuming per-asset assessment fees across global biotech/pharma and specialty healthcare markets, the realistic global annual market for dedicated asset-level commercial assessments is small (low single-digit billions); I estimate ~$1.0B with mid‑single-digit to low‑teens CAGR (~10%).
- Digital asset management market projected to reach USD 14.51 billion by 2031 from USD 6.23 billion in 2025, at a CAGR of 15.4%.
- The global asset management market size was valued at USD 432.77 billion in 2025; CAGR 12.6% during the forecast period.
- US Marketing Analytics Market projected from $5.25 billion in 2025 to $9.56 billion by 2030, CAGR ~12.73%.
Portfolio strategy and prioritization
No explicit market-size or CAGR figures appear in the provided search results. I estimated the market for portfolio strategy and prioritization (scenario modeling and portfolio-level analytics for product pipelines) by: 1) Treating it as a focused subsegment of enterprise product-management/PPM/decision-analytics SaaS (specialist vendors cited: Productboard, airfocus, Zappi, quantilope, Stage-Gate). 2) Using a bottoms-up heuristic: adoption concentrated in mid-to-large enterprises, typical specialist-tool ARR in the low five- to low six-figure range, and a growing vendor ecosystem. 3) Benchmarking growth expectations to adjacent enterprise SaaS and analytics categories where digital transformation, data-driven prioritization, and scenario modeling drive double-digit growth. Combining those factors yields an estimated current global market ≈ $1.5B and a near-term growth potential of ~11% CAGR (driven by increased adoption of analytics/AI, integration with PLM/PPM stacks, and demand for resource-allocation tooling). No individual search result provides explicit market-size or CAGR figures, so no direct citations for numeric values are available.
Investor and deal due diligence
Estimate based on explicit commercial-due-diligence figures in the provided results. A specialist summary (InvestorDataRooms citing Business Research Insights) reports the global commercial due diligence market at USD 2.33B (2025) with a 7.8% CAGR. A broader due-diligence services report (Credence Research) shows a larger market (~USD 5.50B in 2024) with a similar ~7.28% CAGR, supporting the selected size and growth as representative of investor/deal due diligence services.
- Evaluate
- Evaluate Pharma
- Evaluate Omnium
- Evaluate Epi
- Custom Model Build
- Pharma Forecasting Platform
- Pharma Forecasting Software
- Pharma Forecasting Training
- Pharma Forecasting Support
- Japan Drug Forecasts
- Europe Drug Forecasts
- BioSciDB
- Biomedtracker
- Datamonitor Healthcare
- Custom Analytics
- Competitive Intelligence
- Portfolio Optimization & Asset Strategy
- Business Development & Licensing
- Pharmaceutical market size marked US$ 1772.65 billion in 2025; CAGR, 2026-2035 6.15%.
- The global pharmaceutical market is on a trajectory to surpass $1.7 trillion by 2030.
- Digital asset management market projected to reach USD 14.51 billion by 2031 from USD 6.23 billion in 2025, at a CAGR of 15.4%.
- The global asset management market size was valued at USD 432.77 billion in 2025; CAGR 12.6% during the forecast period.
- US Marketing Analytics Market projected from $5.25 billion in 2025 to $9.56 billion by 2030, CAGR ~12.73%.
- valued at USD 2.33 billion in 2025; CAGR of 7.8%.
- reached USD 5,501.93 million in 2024; CAGR of 7.28%.
This is a public preview. Whoever claims it decides what it shows.
This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.
Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.
Built from public web sources. Request removal →
How AI sees this company
This is what AI systems and crawlers receive for this page — the metadata and structured data, and the Markdown profile, served alongside the human-readable content.